½ÃÀ庸°í¼­
»óǰÄÚµå
1760572

¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå º¸°í¼­(2025³â)

Interventional Lung Solutions Global Market Report 2025

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 175 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â°£ °­ÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ¸ð´ÏÅ͸µÀÇ È®»ê, °³ÀÎÈ­ ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡, ·Îº¿ º¸Á¶ ¼ö¼úÀÇ Àα⠻ó½Â, ÃÖ¼Ò Ä§½ÀÀû ÀýÂ÷ÀÇ È®»ê, Á¤¹Ð ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡ µî¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ ±â°£ µ¿¾È ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÷´Ü Æó¾Ï Ä¡·á¹ý °³¹ß, ±â°üÁö ³»½Ã°æ ½Ã½ºÅÛ¿¡ Àΰø Áö´É ÅëÇÕ, ÁßÀçÀû ÆóÇÐ ¹× Á¾¾ç Ä¡·áÀÇ ÅëÇÕ, Æó Áúȯ °ü¸®¸¦ À§ÇÑ µðÁöÅÐ Ç÷§Æû ÅëÇÕ, Æó Àç»ý Ä¡·áÀÇ Çõ½Å µîÀÌ ÀÖ½À´Ï´Ù.

È£Èí±â ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÇâÈÄ ¸î ³â µ¿¾È ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀåÀÇ È®ÀåÀÌ Å©°Ô ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. È£Èí±â ÁúȯÀº Æó¿Í ±âµµ¿¡ ¿µÇâÀ» ¹ÌÃÄ È£ÈíÀ» ¹æÇØÇϰí Á¤»óÀûÀΠȣÈí ±â´ÉÀ» ¹æÇØÇÏ´Â ´Ù¾çÇÑ ÀÇ·áÀû »óŸ¦ Æ÷ÇÔÇÕ´Ï´Ù. È£Èí±â ÁúȯÀÇ Áõ°¡ ´Â ÁÖ·Î ´ë±â ¿À¿° ¼öÁØ Áõ°¡·Î ÀÎÇØ À¯ÇØÇÑ °ø±â Áß ÀÔÀÚ ¹× Àڱع°Áú¿¡ Àå±â°£ ³ëÃâµÇ´Â °ÍÀÌ ÁÖ¿ä ¿øÀÎÀ¸·Î Áö¸ñµË´Ï´Ù. Æó ÁßÀçÀû ¼Ö·ç¼ÇÀº ¸¸¼º Æó Áúȯ ȯÀÚÀÇ Æó ±â´ÉÀ» °³¼±Çϰí Áõ»óÀ» ¿ÏÈ­ÇÏ´Â ÃÖ¼Ò Ä§½ÀÀû ÀýÂ÷¸¦ Á¦°øÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ÁúȯÀ» °ü¸®ÇÏ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 11¿ù, ¹Ì±¹ Á¤ºÎ ±â°üÀÎ Áúº´ÅëÁ¦¿¹¹æ¼¾ÅÍ(CDC)´Â 2022³â ¹Ì±¹¿¡¼­ ¾à 8,331°ÇÀÇ °áÇÙ »ç·Ê°¡ º¸°íµÇ¾î Àü³âµµ¿¡ ºñÇØ 5.9% Áõ°¡Çß´Ù°í ¹àÇû½À´Ï´Ù. È£Èí±â ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϸ鼭 ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀåÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.

ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº Æó¾Ï Áø´ÜÀÇ Á¤È®¼ºÀ» ³ôÀ̰í, ÃÖ¼Ò Ä§½ÀÀû ½Ã¼úÀ» °¡´ÉÇÏ°Ô Çϸç, ÷´Ü ³»ºñ°ÔÀÌ¼Ç ¹× »ý°Ë ±â´ÉÀ» ÅëÇØ ȯÀÚÀÇ Ä¡·á °á°ú¸¦ °³¼±Çϱâ À§ÇØ Ion Endoluminal System°ú °°Àº Ãֽűâ¼úÀÇ °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. Ion Endoluminal SystemÀº ÃÖ¼Ò Ä§½ÀÀû Æó ½Ã¼úÀ» À§ÇØ ¼³°èµÈ ·Îº¿ º¸Á¶ Ç÷§ÆûÀ¸·Î, À۰ųª Á¢±ÙÀÌ ¾î·Á¿î Æó °áÀý¿¡ Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï Á¤È®ÇÑ ±âµµ ³»ºñ°ÔÀ̼ÇÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 4¿ù ¹Ì±¹ ±â¹Ý ºñ¿µ¸® ±â°üÀÎ H. Lee Moffitt ¾Ï ¼¾ÅÍ ¹× ¿¬±¸¼Ò Àç´Ü(H. Lee Moffitt Cancer Center and Research Institute Foundation Inc.)Àº °í±Þ ±¤¼¶À¯ ±â¼ú°ú ÃÖ¼Ò Ä§½ÀÀû Ä«Å×ÅÍ ½Ã½ºÅÛÀ» °áÇÕÇÑ »õ·Î¿î Ion Robotic Bronchoscopy Ç÷§ÆûÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ±â¼úÀº ±¤¼¶À¯¿Í ½ÃÀå¿¡¼­ °¡Àå ÀÛÀº Ä«Å×Å͸¦ Ȱ¿ëÇØ ÆóÀÇ ¸ðµç ºÎÀ§¿¡ Á¢±ÙÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº 180¡Æ ȸÀüÀÌ °¡´ÉÇÑ ÃʹÚÇü, ±âµ¿¼ºÀÌ ¶Ù¾î³­ Ä«Å×ÅÍ, ÅëÇÕµÈ ½Ç½Ã°£ ¿µ»ó, Çü»ó °¨Áö ±â¼úÀ» Ư¡À¸·Î Çϸç, Á¢±ÙÀÌ ¾î·Á¿î ¸»ÃÊ Æó °áÀýÀÇ Á¤¹ÐÇÑ Å½»ö ¹× »ý°ËÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº Á¶Á÷ »ùÇøµ¿¡ Àü·Ê ¾ø´Â ¾ÈÁ¤¼º°ú Á¤È®¼ºÀ» Á¦°øÇÏ¿© Àǻ簡 18°³ Æó ºÎÀ§ ¸ðµÎ¿¡ Á¢±ÙÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á, ÃÊ±â Æó¾ÏÀÇ ¹ß°ß·üÀ» Çâ»ó½Ãŵ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª 19 ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

  • ¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç: PESTEL ºÐ¼®(Á¤Ä¡, »çȸ, ±â¼ú, ȯ°æ, ¹ýÀû ¿äÀÎ, ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀÎ)
  • ÃÖÁ¾ ÀÌ¿ë »ê¾÷ÀÇ ºÐ¼®
  • ¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå : ¼ºÀå·ü ºÐ¼®
  • ¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå ½ÇÀû: ±Ô¸ð¿Í ¼ºÀå(2019-2024³â)
  • ¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå ¿¹Ãø : ±Ô¸ð¿Í ¼ºÀå(2024-2029³â, 2034³â)
  • ¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç : ÃÑ Àüü ½ÃÀå ±Ô¸ð(TAM)

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå : Á¦Ç° À¯Çüº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ±â°üÁö ³»½Ã°æ
  • ±â°üÁö³» ÃÊÀ½ÆÄ ħ
  • Èä°­°æ
  • ±âµµ ½ºÅÙÆ®
  • ±âŸ Á¦Ç° À¯Çü
  • ¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå : ±â¼úº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ·Îº¿ ¼ö¼ú
  • ·¹ÀÌÀú ¿ä¹ý
  • ÀüÀڱ⠳»ºñ°ÔÀÌ¼Ç ±â°üÁö ³»½Ã°æ °Ë»ç
  • ¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå : óġº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ±â°üÁö ³»½Ã°æ °Ë»ç
  • Èä°­°æ °Ë»ç
  • È丷°æ °Ë»ç
  • ±âŸ ó¸®
  • ¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå : ¿ëµµº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • Æó¾Ï Ä¡·á
  • ¸¸¼º Æó»ö¼º ÆóÁúȯ
  • ¼ö¸é ¹«È£Èí ÁõÈıº Ä¡·á
  • ¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Àü¹® Ŭ¸®´Ð
  • ±âŸ ÃÖÁ¾ »ç¿ëÀÚ
  • ¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå : ±â°üÁö ³»½Ã°æ À¯Çüº° ¼¼ºÐÈ­, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • À¯¿¬ÇÑ ±â°üÁö ³»½Ã°æ
  • °æÈ­ ±â°üÁö ³»½Ã°æ
  • ÀÏȸ¿ë ±â°üÁö ³»½Ã°æ
  • ¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå : ±â°üÁö³» ÃÊÀ½ÆÄ ħ À¯Çüº° ¼¼ºÐÈ­, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • °æ±â°üÁö ÈíÀÔ Ä§
  • »ý°Ë ħ
  • ¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå : Èä°­°æ À¯Çüº° ¼¼ºÐÈ­, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • À¯¿¬ÇÑ Èä°­°æ
  • ¹Ý°æÈ­ Èä°­°æ
  • ¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå : ±âµµ ½ºÅÙÆ® À¯Çüº° ¼¼ºÐÈ­, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ±Ý¼Ó ½ºÅÙÆ®
  • ½Ç¸®ÄÜ ½ºÅÙÆ®
  • ÇÏÀ̺긮µå ½ºÅÙÆ®
  • ¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå : ±âŸ Á¦Ç° À¯Çüº° ¼¼ºÐÈ­, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ±â°üÁö¿­ ¼ºÇü¼ú¿ë ÀåÄ¡
  • Æó¿ë·® °¨¼Ò ÀåÄ¡
  • ÀüÀÚ Ç×Çà ½Ã½ºÅÛ
  • µ¿°á¿ä¹ý ¹× ÀýÁ¦ÀåÄ¡

Á¦7Àå Áö¿ªº°, ±¹°¡º° ºÐ¼®

  • ¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå : Áö¿ªº°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå : ±¹°¡º°, ºÐ¼®°ú ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå : °æÀï ±¸µµ
  • ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå : ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Johnson and Johnson : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®
    • Siemens AG : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®
    • Medtronic plc : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®
    • FUJIFILM Holdings Corporation : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®
    • GE Healthcare Technologies Inc. : °³¿ä, Á¦Ç° ¹× ¼­ºñ½º, Àü·« ¹× À繫 ºÐ¼®

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

  • Boston Scientific Corporation
  • Olympus Corporation
  • Intuitive Surgical Inc.
  • Smiths Medical Inc.
  • Cook Medical Inc.
  • Merit Medical Systems Inc.
  • Penumbra Inc.
  • Vygon SA
  • AngioDynamics Inc.
  • Vapotherm Inc.
  • Pulmonx Corporation
  • Broncus Medical Inc.
  • Thirona BV
  • Body Vision Medical Ltd.
  • The Lung Docs Inc.

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

  • ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå(2029³â) : »õ·Î¿î ±âȸ¸¦ Á¦°øÇÏ´Â ±¹°¡
  • ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå(2029³â) : »õ·Î¿î ±âȸ¸¦ Á¦°øÇÏ´Â ºÎ¹®
  • ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå(2029³â) : ¼ºÀå Àü·«
    • ½ÃÀå µ¿Çâ¿¡ ±âÃÊÇÑ Àü·«
    • °æÀï Àü·«

Á¦36Àå ºÎ·Ï

HBR 25.07.10

Interventional lung solutions refer to minimally invasive procedures and technologies designed to diagnose and treat lung conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, and emphysema. These solutions typically include interventions such as bronchoscopy, endobronchial valves, and image-guided therapies, all aimed at improving lung function and enhancing patient outcomes.

The main types of interventional lung solutions include bronchoscopes, endobronchial ultrasound needles, pleuroscopes, airway stents, and other related devices. Bronchoscopes are medical instruments used to visualize and examine the airways and lungs, typically inserted through the nose or mouth to diagnose and treat respiratory conditions. Technologies associated with bronchoscopes include robotic surgery, laser therapy, and electromagnetic navigation bronchoscopy. The procedures involved include bronchoscopy, thoracoscopy, pleuroscopy, and others. These solutions are applied in various medical fields such as lung cancer treatment, COPD management, and sleep apnea treatment, and are used by a variety of end-users, including hospitals, ambulatory surgical centers, specialty clinics, and other healthcare settings.

The interventional lung solutions market research report is one of a series of new reports from The Business Research Company that provides interventional lung solutions market statistics, including the interventional lung solutions industry's global market size, regional shares, competitors with the interventional lung solutions market share, detailed interventional lung solutions market segments, market trends and opportunities, and any further data you may need to thrive in the interventional lung solutions market. This interventional lung solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The interventional lung solutions market size has grown strongly in recent years. It will grow from $2.30 billion in 2024 to $2.49 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to the increasing prevalence of respiratory diseases, the growing number of smokers worldwide, rising air pollution levels, increasing healthcare awareness, and the growing number of lung cancer cases.

The interventional lung solutions market size is expected to see strong growth in the next few years. It will grow to $3.43 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to the growing adoption of telemedicine and remote monitoring, an increasing focus on personalized medicine, the rising popularity of robotic-assisted surgery, the growing adoption of minimally invasive procedures, and an increasing focus on precision medicine. Major trends expected during this period include the development of advanced lung cancer interventions, the integration of artificial intelligence in bronchoscopy systems, the merging of interventional pulmonology with oncology treatments, the integration of digital platforms for lung disease management, and innovations in lung regeneration therapies.

The growing prevalence of respiratory diseases is expected to significantly drive the expansion of the interventional lung solutions market in the coming years. Respiratory diseases encompass a range of medical conditions that affect the lungs and airways, impairing breathing and disrupting normal respiratory function. The increase in respiratory diseases is largely attributed to rising levels of air pollution, which contribute to prolonged exposure to harmful airborne particles and irritants. Interventional lung solutions assist in managing these diseases by providing minimally invasive procedures that improve lung function and alleviate symptoms in patients with chronic pulmonary conditions. For example, in November 2023, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported approximately 8,331 tuberculosis cases in the United States in 2022, marking a 5.9% increase from the previous year. This growing prevalence of respiratory diseases is driving the growth of the interventional lung solutions market.

Key players in the interventional lung solutions market are focusing on the development of cutting-edge technologies, such as the Ion Endoluminal System, to enhance the accuracy of lung cancer diagnostics, enable minimally invasive procedures, and improve patient outcomes through advanced navigation and biopsy capabilities. The Ion Endoluminal System is a robotic-assisted platform designed for minimally invasive lung procedures, enabling precise airway navigation to access small or difficult-to-reach lung nodules. For example, in April 2024, the H. Lee Moffitt Cancer Center and Research Institute Foundation Inc., a US-based non-profit organization, launched a new Ion Robotic Bronchoscopy platform to enhance their interventional pulmonology program with advanced fiber-optic technology and a minimally invasive catheter system. This technology employs fiber optics and the smallest catheter available on the market to access all areas of the lungs. It features an ultra-thin, highly maneuverable catheter with 180° articulation, integrated real-time vision, and shape-sensing technology, enabling precise navigation and biopsy of peripheral lung nodules that are difficult to reach. This system offers unprecedented stability and accuracy for tissue sampling, enabling physicians to reach all 18 lung segments, thus improving the detection of early-stage lung cancer.

In February 2025, Stryker Corporation, a US-based medical device company, acquired Inari Medical Inc. for an undisclosed amount. This acquisition is aimed at strengthening Stryker's interventional endovascular portfolio by adding innovative thrombolytic-free solutions for treating venous thromboembolism (VTE), including pulmonary embolism and deep vein thrombosis. Inari Medical Inc., based in the US, specializes in providing interventional solutions for pulmonary conditions, with a particular focus on treating pulmonary embolism (PE).

Major players in the interventional lung solutions market are Johnson and Johnson, Siemens AG, Medtronic plc, FUJIFILM Holdings Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Smiths Medical Inc., Cook Medical Inc., Merit Medical Systems Inc., Penumbra Inc., Vygon SA, AngioDynamics Inc., Vapotherm Inc., Pulmonx Corporation, Broncus Medical Inc., Thirona B.V., Body Vision Medical Ltd., The Lung Docs Inc., EndoMed Systems GmbH.

North America was the largest region in the interventional lung solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interventional lung solutions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the interventional lung solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The interventional lung solutions market consists of revenues earned by entities by providing services such as endobronchial valve placement, navigational bronchoscopy, lung volume reduction, and airway stenting. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional lung solutions market also consists of sales of products including bronchial thermoplasty devices, cryotherapy devices, bronchial stents, and biopsy forceps. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Lung Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interventional lung solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional lung solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The interventional lung solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Bronchoscopes; Endobronchial Ultrasound Needles; Pleuroscopes; Airway Stents; Other Product Types
  • 2) By Technology: Robotic Surgery; Laser Therapy; Electromagnetic Navigation Bronchoscopy
  • 3) By Procedure: Bronchoscopy; Thoracoscopy; Pleuroscopy; Other Procedures
  • 4) By Application: Lung Cancer Treatment; Chronic Obstructive Pulmonary Disease; Sleep Apnea Treatment
  • 5) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) BY Bronchoscopes: Flexible Bronchoscopes; Rigid Bronchoscopes; Disposable Bronchoscopes
  • 2) By Endobronchial Ultrasound Needles: Transbronchial Aspiration Needles; Biopsy Needles
  • 3) By Pleuroscopes: Flexible Pleuroscopes; Semi-Rigid Pleuroscopes
  • 4) By Airway Stents: Metallic Stents; Silicone Stents; Hybrid Stents
  • 5) By Other Product Types: Bronchial Thermoplasty Devices; Lung Volume Reduction Devices; Electromagnetic Navigation Systems; Cryotherapy And Ablation Devices
  • Companies Mentioned: Johnson and Johnson; Siemens AG; Medtronic plc; FUJIFILM Holdings Corporation; GE Healthcare Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Interventional Lung Solutions Market Characteristics

3. Interventional Lung Solutions Market Trends And Strategies

4. Interventional Lung Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Interventional Lung Solutions Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Interventional Lung Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Interventional Lung Solutions Market Growth Rate Analysis
  • 5.4. Global Interventional Lung Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Interventional Lung Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Interventional Lung Solutions Total Addressable Market (TAM)

6. Interventional Lung Solutions Market Segmentation

  • 6.1. Global Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bronchoscopes
  • Endobronchial Ultrasound Needles
  • Pleuroscopes
  • Airway Stents
  • Other Product Types
  • 6.2. Global Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Robotic Surgery
  • Laser Therapy
  • Electromagnetic Navigation Bronchoscopy
  • 6.3. Global Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bronchoscopy
  • Thoracoscopy
  • Pleuroscopy
  • Other Procedures
  • 6.4. Global Interventional Lung Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lung Cancer Treatment
  • Chronic Obstructive Pulmonary Disease
  • Sleep Apnea Treatment
  • 6.5. Global Interventional Lung Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Other End-Users
  • 6.6. Global Interventional Lung Solutions Market, Sub-Segmentation Of Bronchoscopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Flexible Bronchoscopes
  • Rigid Bronchoscopes
  • Disposable Bronchoscopes
  • 6.7. Global Interventional Lung Solutions Market, Sub-Segmentation Of Endobronchial Ultrasound Needles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transbronchial Aspiration Needles
  • Biopsy Needles
  • 6.8. Global Interventional Lung Solutions Market, Sub-Segmentation Of Pleuroscopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Flexible Pleuroscopes
  • Semi-Rigid Pleuroscopes
  • 6.9. Global Interventional Lung Solutions Market, Sub-Segmentation Of Airway Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metallic Stents
  • Silicone Stents
  • Hybrid Stents
  • 6.10. Global Interventional Lung Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bronchial Thermoplasty Devices
  • Lung Volume Reduction Devices
  • Electromagnetic Navigation Systems
  • Cryotherapy And Ablation Devices

7. Interventional Lung Solutions Market Regional And Country Analysis

  • 7.1. Global Interventional Lung Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Interventional Lung Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Interventional Lung Solutions Market

  • 8.1. Asia-Pacific Interventional Lung Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Interventional Lung Solutions Market

  • 9.1. China Interventional Lung Solutions Market Overview
  • 9.2. China Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Interventional Lung Solutions Market

  • 10.1. India Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Interventional Lung Solutions Market

  • 11.1. Japan Interventional Lung Solutions Market Overview
  • 11.2. Japan Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Interventional Lung Solutions Market

  • 12.1. Australia Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Interventional Lung Solutions Market

  • 13.1. Indonesia Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Interventional Lung Solutions Market

  • 14.1. South Korea Interventional Lung Solutions Market Overview
  • 14.2. South Korea Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Interventional Lung Solutions Market

  • 15.1. Western Europe Interventional Lung Solutions Market Overview
  • 15.2. Western Europe Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Interventional Lung Solutions Market

  • 16.1. UK Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Interventional Lung Solutions Market

  • 17.1. Germany Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Interventional Lung Solutions Market

  • 18.1. France Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Interventional Lung Solutions Market

  • 19.1. Italy Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Interventional Lung Solutions Market

  • 20.1. Spain Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Interventional Lung Solutions Market

  • 21.1. Eastern Europe Interventional Lung Solutions Market Overview
  • 21.2. Eastern Europe Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Interventional Lung Solutions Market

  • 22.1. Russia Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Interventional Lung Solutions Market

  • 23.1. North America Interventional Lung Solutions Market Overview
  • 23.2. North America Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Interventional Lung Solutions Market

  • 24.1. USA Interventional Lung Solutions Market Overview
  • 24.2. USA Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Interventional Lung Solutions Market

  • 25.1. Canada Interventional Lung Solutions Market Overview
  • 25.2. Canada Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Interventional Lung Solutions Market

  • 26.1. South America Interventional Lung Solutions Market Overview
  • 26.2. South America Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Interventional Lung Solutions Market

  • 27.1. Brazil Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Interventional Lung Solutions Market

  • 28.1. Middle East Interventional Lung Solutions Market Overview
  • 28.2. Middle East Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Interventional Lung Solutions Market

  • 29.1. Africa Interventional Lung Solutions Market Overview
  • 29.2. Africa Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Interventional Lung Solutions Market Competitive Landscape And Company Profiles

  • 30.1. Interventional Lung Solutions Market Competitive Landscape
  • 30.2. Interventional Lung Solutions Market Company Profiles
    • 30.2.1. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. FUJIFILM Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Interventional Lung Solutions Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Olympus Corporation
  • 31.3. Intuitive Surgical Inc.
  • 31.4. Smiths Medical Inc.
  • 31.5. Cook Medical Inc.
  • 31.6. Merit Medical Systems Inc.
  • 31.7. Penumbra Inc.
  • 31.8. Vygon SA
  • 31.9. AngioDynamics Inc.
  • 31.10. Vapotherm Inc.
  • 31.11. Pulmonx Corporation
  • 31.12. Broncus Medical Inc.
  • 31.13. Thirona B.V.
  • 31.14. Body Vision Medical Ltd.
  • 31.15. The Lung Docs Inc.

32. Global Interventional Lung Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Interventional Lung Solutions Market

34. Recent Developments In The Interventional Lung Solutions Market

35. Interventional Lung Solutions Market High Potential Countries, Segments and Strategies

  • 35.1 Interventional Lung Solutions Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Interventional Lung Solutions Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Interventional Lung Solutions Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦